Cargando…
晚期非小细胞肺癌RRM1蛋白表达与吉西他滨联合顺铂化疗疗效的关系
BACKGROUND AND OBJECTIVE: It has been proven that ribonucleotide reductase M1 (RRM1) expression level was closely related to gemcitabine drug-resistance to tumor cells. Te aim of this study is to explore the relations between RRM1 protein expression levels and effects of gemcitabine and cisplatin ch...
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
中国肺癌杂志编辑部
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5999711/ https://www.ncbi.nlm.nih.gov/pubmed/21496433 http://dx.doi.org/10.3779/j.issn.1009-3419.2011.04.07 |
Ejemplares similares
-
吉西他滨联合奥沙利铂或顺铂一线治疗老年晚期非小细胞肺癌的随机研究
Publicado: (2011) -
培美曲塞联合顺铂对比吉西他滨联合顺铂一线治疗晚期非鳞非小细胞肺癌的随机、对照、多中心临床研究
Publicado: (2012) -
培美曲塞联合铂类对比吉西他滨联合铂类治疗晚期非小细胞肺癌的meta分析
Publicado: (2011) -
吉西他滨顺铂联合索拉非尼或安慰剂一线治疗晚期非小细胞肺癌的随机对照研究
Publicado: (2011) -
培美曲塞及吉西他滨分别联合顺铂治疗初治晚期非小细胞肺癌安全性和有效性的随机对照研究
Publicado: (2012)